FGF1 effectively blocks diabetes-induced neuronal apoptosis and BDNF reduction, consequently ameliorates DICD though inhibiting PERK signaling and promoting PI3K/AKT signaling (Fig. 9l). This evidence concerns the gene AKT1 and diabetes mellitus.